IQV vs MEDP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 31, 2026

IQV

62.2
AI Score
VS
MEDP Wins

MEDP

62.3
AI Score

Investment Advisor Scores

IQV

Jul 31, 2026
62score
Recommendation
BUY

MEDP

Jul 31, 2026
62score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric IQV MEDP Winner
Forward P/E 19.0114 31.6456 IQV
PEG Ratio 0.9791 3.2688 IQV
Revenue Growth 8.7% 17.2% MEDP
Earnings Growth -0.6% 37.1% MEDP
Tradestie Score 62.2/100 62.3/100 MEDP
Profit Margin 8.1% 17.7% MEDP
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation BUY BUY Tie

Relative Price Performance (Last 90 Days)

IQV 1M: +15.7% · 3M: +48.4% MEDP 1M: +6.2% · 3M: +37.8%

Current Technical Phase

IQV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.2% over 20 days), RSI 68

RSI (14): 68.1 · Price: $235.02

MEDP

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.6% over 20 days), RSI 61

RSI (14): 61.5 · Price: $577.11

Fundamentals Snapshot

Metric IQV MEDP
Market Cap
Forward P/E 16.3 32.3
Trailing P/E 29.2 33.4
Revenue (TTM)
Revenue Growth 0.1% 0.2%
Gross Margin 0.3% 0.7%
Operating Margin 0.1% 0.2%
EPS 8.04 15.79
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MEDP is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.